TIETOJA TÄSTÄ JAKSOSTA
Join Creative Biolabs and Dr. Melita Irving to explore engineering strategies for adoptive T-cell therapy against cancer. This webinar examines tumor microenvironment barriers, co-engineered CAR-T cells, low-dose irradiation, and STOP-CAR design, highlighting approaches to improve T-cell function and integrate efficacy and safety into next-generation CAR and TCR therapies.
Englanti
Yhdysvallat
TRANSKRIPTIO 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
HAE EDELLISIÄ EPISODEJA
Hae kanavan The antibody-based pharmaceuticals resource library’s Podcast vanhoja jaksoja.
MUITA jaksoja TÄSSÄ PODCASTISSA
Join Creative Biolabs and Dr. Eytan Herzig to explore convertibleCAR-T technology for HIV research. This webinar explains how engineered T cells and HIV-targeting MicAbodies work together to recognize infected cells, highlighting the platform's modularity, multiplexed antibody targeting, and practi…
Join Creative Biolabs and Dr. Francisco J. Quintana to explore how astrocytes regulate central nervous system inflammation. This webinar examines their functions in health and disease, cell-cell interactions, and long-term epigenetic control, highlighting emerging methods and research directions fo…
Join Creative Biolabs and Dr. James Naismith to explore the development of SARS-CoV-2 neutralizing single-domain antibodies. This webinar highlights a candidate showing promising therapeutic efficacy in a Syrian golden hamster model of COVID-19, offering insights into antibody development and the p…
Join Creative Biolabs and Dr. Bruno Paiva to explore new approaches to evaluating the tumor immune microenvironment. This webinar examines blood cancer and immunity, B-cell maturation antigen, bispecific antibodies, myeloid-derived suppressor cells, and immune escape, connecting insights into tumor…
Vastuuvapautusilmoitus: Tälle sivulle upotettu podcast ja kuvitus ovat peräisin antibodybasedpharmaceuticalsresourcelibrary:ltä, joka on sen omistajan omaisuutta, eikä se ole sidoksissa Listen Notes, Inc:n tukemaan.
MUOKKAA
Kiitos, kun autoit pitämään podcast-tietokantaa ajan tasalla.